Stereotaxis Inc

NYSE American:STXSUnited States

Operating loss (6,345) (5,639) (17,112) (16,535) Other income 5 - 2 27 Interest income, net 150 270 580 835 ---------- ---------- ---------- ---------- Net loss $ (6,190) $ (5,369) $ (16,530) $ (15,673) Cumulative dividend on convertible preferred stock (328) (338) (984) (1,004) ---------- Net loss attributable to common stockholders $ (6,518) $ (5,707) $ (17,514) $ (16,677) ========== ========== ========== ========== Net loss per share attributed to common stockholders: Basic $ (0.08) $ (0.07) $ (0.21) $ (0.21) Diluted $ (0.08) $ (0.07) $ (0.21) $ (0.21) Weighted average number of common shares and equivalents: Basic 85,824,789 82,468,971 84,629,531 80,028,243 Diluted 85,824,789 82,468,971 84,629,531 80,028,243 STEREOTAXIS, INC. BALANCE SHEETS September 30, December 31, (in thousands, except share amounts) 2024 2023 --------------- ---------------- (Unaudited) Assets Current assets: Cash and cash equivalents $ 10,663 $ 19,818 Restricted cash - current 350 525 Accounts receivable, net of allowance of $661 and $672 at 2024 and 2023, respectively 7,921 3,822 Inventories, net 9,009 8,426 Prepaid expenses and other current assets 869 676 ---------- --------- Total current assets 28,812 33,267 Property and equipment, net 3,733 3,304 Goodwill 4,494 - Intangible assets 8,162 - Restricted cash - 219 Operating lease right-of-use assets 5,618 4,982 Prepaid and other non-current assets 116 137 ---------- --------- Total assets $ 50,935 $ 41,909 ========== ========= Liabilities and stockholders' equity Current liabilities: Accounts payable $ 6,403 $ 3,190 Accrued liabilities 3,376 2,972 Deferred revenue 5,092 6,657 Current contingent consideration 5,298 - Current portion of operating lease liabilities 552 428 ---------- --------- Total current liabilities 20,721 13,247 Long-term deferred revenue 2,102 1,637 Long-term contingent consideration 6,251 - Operating lease liabilities 5,583 5,062 Other liabilities 55 43 ---------- --------- Total liabilities 34,712 19,989 Series A - Convertible preferred stock: Convertible preferred stock, Series A, par value $0.001; 10,000,000 shares authorized, 21,683 and 22,358 shares outstanding at 2024 and 2023, respectively 5,408 5,577 Stockholders' equity: Common stock, par value $0.001; 300,000,000 shares authorized, 84,713,400 and 80,949,697 shares issued at 2024 and 2023, respectively 85 81 Additional paid-in capital 565,146 554,148 Treasury stock, 4,015 shares at 2024 and 2023 (206) (206) Accumulated deficit (554,210) (537,680) ---------- --------- Total stockholders' equity 10,815 16,343 ---------- --------- Total liabilities and stockholders' equity $ 50,935 $ 41,909 ========== =========

University of Kansas Medical Center Enhances Robotic Heart Care Program with Genesis Robotic Technology

ST. LOUIS, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that physicians at the University of Kansas Health System have successfully treated the first patients using the advanced Genesis Robotic Magnetic Navigation (RMN) System from Stereotaxis.